Cargando…

Myocarditis following rAd26 and rAd5 vector‐based COVID‐19 vaccine: case report

SARS‐CoV‐2 vaccines provide a safe solution with a major impact on reducing the spread of the virus and mild side effects. Research has shown rare cases of myocarditis after mRNA vaccines. This study presents a 29‐year‐old male with chest pain after 48 h of receiving rAd26 and rAd5 vector‐based COVI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Naghashzadeh, Farah, Shafaghi, Shadi, Dorudinia, Atosa, Naji, Seyed Alireza, Marjani, Majid, Amin, Ahmad, Mohamadifar, Arezoo, Noorali, Sima, Kashani, Babak Sharif
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934948/ https://www.ncbi.nlm.nih.gov/pubmed/35106967 http://dx.doi.org/10.1002/ehf2.13821

Ejemplares similares

Myocarditis following rAd26 and rAd5 vector‐based COVID‐19 vaccine: correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Coronavirus disease 2019 outcomes in heart transplant recipients: a single-center case series
por: Naghashzadeh, Farah, et al.
Publicado: (2021)

COVID-19 and Vaccine-Induced Thrombosis
por: Sharif-Kashani, Babak, et al.
Publicado: (2022)

rAd5/NYVAC-B is superior to NYVAC-B/rAd5 and is dependent on rAd5 dose for neutralizing antibody responses against HIV-1
por: Montefiori, DC, et al.
Publicado: (2012)

Remdesivir associated sinus bradycardia in patients with COVID-19: A prospective longitudinal study
por: Hajimoradi, Maryam, et al.
Publicado: (2023)

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
por: Logunov, Denis Y, et al.
Publicado: (2021)

Evaluation of cardiomyopathy diagnosis in heart transplant recipients: comparison of echocardiographic and pathologic classification
por: Behzadnia, Neda, et al.
Publicado: (2021)

Traumatic Transection of Descending Thoracic Aorta Presenting as Pseudo- Coarctation
por: Shafaghi, Shadi, et al.
Publicado: (2018)

Potency, toxicity and protection evaluation of PastoCoAd candidate vaccines: Novel preclinical mix and match rAd5 S, rAd5 RBD-N and SOBERANA dimeric-RBD protein
por: Pouriayevali, Mohammad Hassan, et al.
Publicado: (2022)

Safety and Immunogenicity of a rAd35-EnvA Prototype HIV-1 Vaccine in Combination with rAd5-EnvA in Healthy Adults (VRC 012)
por: Crank, Michelle C., et al.
Publicado: (2016)

Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
por: Logunov, Denis Y, et al.
Publicado: (2020)

Preemptive non-selective bronchial artery angioembolization to reduce recurrence rate of hemoptysis
por: Keshmiri, Mohammad Sadegh, et al.
Publicado: (2020)

Curable Syncope in Primary Pulmonary Hypertension with Novel Atrial Flow Regulator
por: Sharif-Kashani, Babak, et al.
Publicado: (2021)

Protection of homologous and heterologous boosters after primary schemes of rAd26-rAd5, ChAdOx1 nCoV-19 and BBIBP-CorV during the omicron outbreak in adults of 50 years and older in Argentina: a test-negative case–control study
por: González, Soledad, et al.
Publicado: (2023)

rAd5 prime/NYVAC-B boost regimen is superior to NYVAC-B prime/rAd5 boost regimen for both response rates and magnitude of CD4 and CD8 T-cell responses
por: Bart, P, et al.
Publicado: (2012)

Corrigendum to “Potency, toxicity and protection evaluation of PastoCoAd candidate vaccines: Novel preclinical mix and match rAd5 S, rAd5 RBD-N and SOBERANA dimeric-RBD protein” [Vaccine 40(20) (2022) 2856–2868]
por: Pouriayevali, Mohammad Hassan, et al.
Publicado: (2022)

Safety and immunogenicity of rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine against SARS-CoV-2 in healthy adolescents: an open-label, non-randomized, multicenter, phase 1/2, dose-escalation study
por: Tukhvatulin, Amir I., et al.
Publicado: (2023)

Boosting BCG with proteins or rAd5 does not enhance protection against tuberculosis in rhesus macaques
por: Darrah, Patricia A., et al.
Publicado: (2019)

Effectiveness of rAd26-rAd5, ChAdOx1 nCoV-19, and BBIBP-CorV vaccines for risk of infection with SARS-CoV-2 and death due to COVID-19 in people older than 60 years in Argentina: a test-negative, case-control, and retrospective longitudinal study
por: Rearte, Analía, et al.
Publicado: (2022)

Therapeutic effects of lenvatinib in combination with rAd-p53 for the treatment of non-small cell lung cancer
por: Yu, Renzhi, et al.
Publicado: (2018)

Ad26.cov2-s: Myocarditis: case report
Publicado: (2021)

Caspofungin as Salvage Therapy for Pneumocystis Pneumonia in a Heart Transplant Recipient
por: Abolghasemi, Sara, et al.
Publicado: (2018)

A 26 Year-Old Woman with AIDS and Pneumonia
por: Yousefzadeh, Amir, et al.
Publicado: (2013)

Selective intra-arterial infusion of rAd-p53 with chemotherapy for advanced oral cancer: a randomized clinical trial
por: Li, Yi, et al.
Publicado: (2014)

Fission yeast Rad26 responds to DNA damage independently of Rad3
por: Wolkow, Tom D, et al.
Publicado: (2003)

Genomic analysis of Rad26 and Rad1–Rad10 reveals differences in their dependence on Mediator and RNA polymerase II
por: Gopaul, Diyavarshini, et al.
Publicado: (2022)

Synergism therapeutic and immunoregulatory effects of Albendazole + rAd-mIL-28B against Echinococcosis in experiment-infected mice with protoscoleces
por: Zhang, Yan, et al.
Publicado: (2021)

Effects of an Empowerment Program on Self-Care Behaviors and Readmission of Patients with Heart Failure: a Randomized Clinical Trial
por: Dianati, Mansour, et al.
Publicado: (2020)

Heterologous Prime-Boost Regimens Using rAd35 and rMVA Vectors Elicit Stronger Cellular Immune Responses to HIV Proteins Than Homologous Regimens
por: Ratto-Kim, Silvia, et al.
Publicado: (2012)

Atrioventricular Block: A Heralding Sign of Cardiac Allograft Rejection
por: Shafaghi, S., et al.
Publicado: (2020)

The Impact of Adding Digital Breast Tomosynthesis to BI-RADS Categorization of Mammographically Equivocal Breast Lesions
por: Hassan, Rania Mostafa, et al.
Publicado: (2023)

Ad26.COV2-S/elasomeran/tozinameran: Myocarditis: 7 case reports
Publicado: (2022)

P18-06. Increased HIV-specific immunity in HIV-infected individuals vaccinated with a DNA prime, rAd5 boost regimen
por: Casazza, JP, et al.
Publicado: (2009)

Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized Trials
por: Huang, Yunda, et al.
Publicado: (2015)

RAD-R scripts: R pipeline for RAD-seq from FASTQ files to linkage maps construction and run R/QTL, operating only at copying and pasting scripts into R console
por: Seki, Kousuke
Publicado: (2021)

P14-12. Safety and tolerability of VRC DNA and rAd5 HIV-1 vaccine delivery by intramuscular, subcutaneous and intradermal administration in healthy adults
por: Enama, ME, et al.
Publicado: (2009)

Added value of circulating miRNA expression profiling to sonographic TI-RADS classification in the diagnosis of thyroid nodules
por: Mao, Yu, et al.
Publicado: (2020)

Early CD4+ T Cell Responses Are Associated with Subsequent CD8+ T Cell Responses to an rAd5-Based Prophylactic Prime-Boost HIV Vaccine Strategy
por: Lhomme, Edouard, et al.
Publicado: (2016)

Ebola-GP DNA Prime rAd5-GP Boost: Influence of Prime Frequency and Prime/Boost Time Interval on the Immune Response in Non-human Primates
por: Marcus, Hadar, et al.
Publicado: (2021)

Rad51 paralogs Rad55-Rad57 balance the anti-recombinase Srs2 in Rad51 filament formation
por: Liu, Jie, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ad4mmsn6lq719dm37p37qnnql2